# FDA Inspection 1071869 - B & B Pharmaceuticals, Inc. - October 30, 2018

Source: https://www.keypedia.com/records/fda_inspections/b-b-pharmaceuticals-inc/e2b5db68-636f-4659-bc97-d033382e4b7e
Source feed: FDA_Inspections

> FDA Inspection 1071869 for B & B Pharmaceuticals, Inc. on October 30, 2018. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1071869
- Company Name: B & B Pharmaceuticals, Inc.
- Inspection Date: 2018-10-30
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1110384 - 2019-11-18](https://www.keypedia.com/records/fda_inspections/b-b-pharmaceuticals-inc/c16e86ae-5c86-462e-a0dd-565817c7ab2f)
- [FDA Inspection 881892 - 2014-06-11](https://www.keypedia.com/records/fda_inspections/b-b-pharmaceuticals-inc/97b7e365-9d30-454c-ae45-ddd3c0d68063)
- [FDA Inspection 643485 - 2010-02-08](https://www.keypedia.com/records/fda_inspections/b-b-pharmaceuticals-inc/bfa092ef-8313-49ff-b4d6-71120d534b65)

Company: https://www.keypedia.com/companies/b-b-pharmaceuticals-inc/422b4ac5-c374-464f-8f90-06eacfead01e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c